Each session will examine in-depth the implications of the rules, specific business considerations, and practical guidance on compliance and enforcement issues associated with implementation for health care providers, developers of certified health information technology, health plans, and other digital health companies.

This series will broadly be of interest to in-house legal teams, compliance officers, and c-suite executives at health care providers, health plans/payors, health care technology companies, and financial institutions investing in or lending to these entities.

Implications for Tech Transactions: Do I really need to talk to my technology team?

Organizations subject to the Information Blocking and Interoperability requirements will need to assess their patient data sharing practices and the technology they use to share patient data.  The assessment may show they need to change the way their technology operates, whom they permit to access it, and the conditions under which they will not share patient data.  Separately, regulated organizations may also need to consider the contract terms under which their technology is licensed and data is shared with third parties. In this session, we will discuss how you can ask the right questions of your technology team to help meet compliance objectives.  We will also discuss the role of technology licensing agreements and how organizations can thread the needle of including necessary terms to protect intellectual property and data security and allocate risk appropriately without running afoul of the Information Blocking and Interoperability requirements.